Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more INFLUENZAVIRUS A and INFLUENZAVIRUS B strains
Vaccines -- adverse effects -- Congresses : Research strategies for assessing adverse events associated with vaccines : a workshop summary / Committee to Study New Research on Vaccines, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Kathleen R. Stratton, Cynthia J. Howe, and Richard B. Johnston, Jr., editors
Vaccines -- Canada : Public health in the age of anxiety : religious and cultural roots of vaccine hesitancy in Canada / edited by Paul Bramadat, Maryse Guay, Julie A. Bettinger, and Réal Roy
Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumor cells as the source of antigens, or using tumor-specific antigens, often recombinantly produced
Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified
Vaccines -- Congresses -- adverse effects : Research strategies for assessing adverse events associated with vaccines : a workshop summary / Committee to Study New Research on Vaccines, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Kathleen R. Stratton, Cynthia J. Howe, and Richard B. Johnston, Jr., editors
Vaccines -- Development -- United States -- Decision making : Ranking vaccines : a prioritization framework: Phase I: Demonstration of concept and a software blueprint / Committee on Identifying and Prioritizing New Preventive Vaccines for Development, Board on Population Health and Public Health Practice, Board on Global Health ; Guruprasad Madhavan [and others], editors ; Institute of Medicine of the National Academies
Vaccines, DNA -- administration & dosage. : DNA pharmaceuticals : formulation and delivery in gene therapy, DNA vaccination and immunotherapy / edited by Martin Schleef
Vaccines -- Guideline -- United States : Priorities for the national vaccine plan / Committee on Review of Priorities in the National Vaccine Plan, Board on Population Health and Public Health Practice, Institute of Medicine
Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced
